Special issues

Hospitalization exposes fragile patients to additional serious problems, such as antibiotic-resistant secondary infections, emboli, medication side effects or other serious adverse events. Compromised Marshall Protocol (MP) patients may not be able to combat these complications.

The following suggestions are meant to prevent the need for hospitalization and provide guidance for MP patients who find themselves hospitalized or in an emergency situation. MP patients should print out these suggestions, put the document in a folder for easy reference and take it with them to the ER or Urgent Care.

Note that the legal rights associated with medical care and hospitalization set forth in this article are applicable to patients in the United States and may not apply to patients in other countries.

A dentist is one of the medical specialists with whom Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. (MP) patients will have to partner during the course of treatment. Like other parts of the body, teeth can easily be infected by bacteria. One of the benefits of visiting a dentist is that, unlike most other medical specialists, they have the tools to remove bacteria. Some patients find that they need to visit the dentist more frequently due to rapid tartar buildup.

Dentists treat dental symptoms, some of which are associated with periodontal disease. In an MP patient, sometimes a dental symptom, such as a tooth ache, is due to the immunopathological response, and a dental procedure can be delayed if not avoided.

If the need for surgery or diagnostic procedure is not urgent, Marshall Protocol (MP) patients should request that it be postponed until more inflammation is resolved. MP patients who are to receive a local injected anesthetic, such as is given for dental procedures, should request that it not contain any epinephrine (also known as adrenaline). MP patients should also avoid having nitrous oxide used as a sedative.

People are exposed daily to the intracellular microbiota that cause chronic inflammatory diseases. They exist in food, water, injectable medications, body fluids and have even been cultured from dry soil.

As with all injected substances, there is a small risk of introducing these pathogens during the process of tattooing.

Lupus vulgaris over a tattoo mark. Lupus vulgaris is caused by tuberculosis. While tuberculosis is widely accepted as an infectious disease, it is notable that chronic inflammatory diseases of “unknown” origin can also show cutaneous disease-specific lesions following a tattoo. This suggests a common, if not species-specific, pathology.

Researchers have documented that diseases such as lupus vulgaris (painful skin lesions caused by M. tuberculosis bacteria) can be induced by a tattoo procedure.¹⁾ Tuberculosis, of course, is unquestionably a bacterial illness.

But the literature also contains multiple reports of sarcoidosis patients – a disease of supposedly unknown origin – also developing skin lesions within tattoos. According to one researcher, this is “a well-recognized occurrence in patients with sarcoidosis.”²⁾ Ali reviews dozens of cases in which granuloma have formed, more often than not, years after the application of a tattoo.³⁾ More than one case report describes how a patient developed sarcoidal granulomas in only one pigment of a tattoo⁴⁾ – which suggests that the needle corresponding to that pigment was infected.

There are a number of explanations for how a tattoo could cause this reaction, but the most logical one is that tattoo needles introduce new pathogens into the skin. For one, the fact that sarcoid granuloma appear years after the application of a tattoo corresponds nicely with the length of time it takes for bacteria to grow.

Marshall Protocol (MP) patients who develop a bulls-eye rash after a tick bite or who think a tick bite has put them at risk for Lyme disease should ask their physician about taking 100mg of minocyclineBacteriostatic antibiotic used by Marshall Protocol patients. twice daily for 30 days.

The question of whether vaccines routinely contribute to chronic disease such as autism has been a contentious one. A number of recent reviews emphasize that vaccines are safe, but there have been several examples of vaccines that have been contaminated by pathogens. The slow-growing nature of chronic pathogens means there may be more cases of contamination than we realize.

Marshall Protocol (MP) patients should examine the costs and benefits of taking any kind of injectable preparation which contains substances synthesized from organisms.

Flu vaccines may be important to prevent acute infections, the acquisition of which can substantially set back progress on the MP.

Patients should follow their doctors' advice regarding the immunizations they feel are essential.

Children with a range of diseases and conditions can be treated with the Marshall Protocol (MP). There are more than a dozen in the study cohort who are doing well, and many others who are being treated by family physicians, not part of the formal study. Benicar is approved by the FDA for use in children and adolescents 6 to 16 years of age.

Both olmesartan (Benicar) and minocycline, the two mainstay medications of the MP, are contraindicated during pregnancy and while breastfeeding. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected in women on the MP, they must discontinue olmesartan (Benicar) as soon as possible. Also, minocycline hydrochloride, like other tetracycline-class antibiotics, can cause fetal harm when administered to a pregnant woman.

Women who are contemplating pregnancy should consult with their physicians about treating inflammatory disease first. Women with inflammatory disease who are already pregnant should do everything possible to keep the level of 1,25-D down. This means diligent avoidance of ingested vitamin D and exposure to sunlight/bright lights.

Some Marshall Protocol (MP) patients may be unable to work due to the severity of their symptoms. Some of them may be eligible to receive disability income through government-sponsored programs or private insurance.